Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

SENORES PHARMACEUTICALS L (SENORES.NS)

517.05
-15.45
(-2.90%)
At close: April 25 at 3:29:55 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Total Revenue
3,827,470
2,107,870
353,260
140,680
Cost of Revenue
1,736,600
1,111,600
127,660
80,340
Gross Profit
2,090,870
996,270
225,600
60,340
Operating Expense
1,317,200
680,200
116,660
47,870
Operating Income
773,670
316,070
108,940
12,470
Net Non Operating Interest Income Expense
-188,170
-89,870
-20,990
-3,720
Pretax Income
675,040
249,440
124,370
11,430
Tax Provision
129,460
-77,640
40,040
1,520
Net Income Common Stockholders
566,650
314,550
84,330
9,910
Diluted NI Available to Com Stockholders
566,650
314,550
84,330
9,910
Basic EPS
12.30
6.83
1.83
0.22
Diluted EPS
12.30
6.83
1.83
0.22
Basic Average Shares
46,053.59
46,053.59
46,053.59
46,053.59
Diluted Average Shares
46,053.59
46,053.59
46,053.59
46,053.59
Rent Expense Supplemental
--
8,970
1,400
140
Total Expenses
3,053,800
1,791,800
244,320
128,210
Net Income from Continuing & Discontinued Operation
566,650
314,550
84,330
9,910
Normalized Income
566,932.88
314,795
84,350.34
9,910
Interest Income
--
4,590
390
1,930
Interest Expense
183,300
85,000
18,370
5,100
Net Interest Income
-188,170
-89,870
-20,990
-3,720
EBIT
858,340
334,440
142,740
16,530
EBITDA
1,011,520
434,620
160,530
23,580
Reconciled Cost of Revenue
1,736,600
1,111,600
127,660
80,340
Reconciled Depreciation
153,180
100,180
17,790
7,050
Net Income from Continuing Operation Net Minority Interest
566,650
314,550
84,330
9,910
Total Unusual Items Excluding Goodwill
-350
-350
-30
--
Total Unusual Items
-350
-350
-30
--
Normalized EBITDA
1,011,870
434,970
160,560
23,580
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-67.12
-105
-9.66
--
3/31/2022 - 12/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MARKSANS.NS Marksans Pharma Limited
216.03
-5.40%
 
DSNKY Daiichi Sankyo Company, Limited
24.85
+0.44%
 
NVS Novartis AG
112.14
+0.87%
 
AMGN Amgen Inc.
280.84
+0.36%
 
GILD Gilead Sciences, Inc.
103.17
-2.81%
 
NVO Novo Nordisk A/S
62.08
-0.88%
 
BMY Bristol-Myers Squibb Company
47.90
-1.62%
 
MRK Merck & Co., Inc.
82.74
+3.63%
 
PFE Pfizer Inc.
22.92
+0.61%
 
LLY Eli Lilly and Company
884.54
+2.89%